Total Payments
$4,452
2024 Payments
$54.59
Companies
37
Transactions
329
Medicare Patients
10,096
Medicare Billing
$431,523
Payment Breakdown by Category
Food & Beverage$4,324 (97.1%)
Education$127.21 (2.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,324 | 324 | 97.1% |
| Education | $127.21 | 5 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $739.97 | 79 | $0 (2020) |
| GlaxoSmithKline, LLC. | $578.80 | 45 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $404.41 | 16 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $363.35 | 28 | $0 (2020) |
| Astellas Pharma US Inc | $266.83 | 17 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $262.94 | 23 | $0 (2019) |
| PFIZER INC. | $216.48 | 17 | $0 (2024) |
| Lilly USA, LLC | $191.60 | 15 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $172.35 | 12 | $0 (2018) |
| Grifols USA, LLC | $154.72 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $54.59 | 3 | Oyster Point Pharma, Inc. ($23.56) |
| 2022 | $102.00 | 6 | Biohaven Pharmaceutical Holding Company Ltd. ($39.89) |
| 2021 | $153.83 | 12 | Astellas Pharma US Inc ($121.02) |
| 2020 | $172.49 | 12 | Novo Nordisk Inc ($70.45) |
| 2019 | $1,100 | 87 | GlaxoSmithKline, LLC. ($188.30) |
| 2018 | $1,480 | 104 | Novo Nordisk Inc ($267.97) |
| 2017 | $1,389 | 105 | Novo Nordisk Inc ($224.74) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: VACCINES | ||||||
| 05/15/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Dry eyes | ||||||
| 05/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Diabetes Care | ||||||
| 09/30/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Bone Health | ||||||
| 09/24/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: PRIMARY CARE | ||||||
| 08/19/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: PRIMARY CARE | ||||||
| 08/12/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: VACCINES | ||||||
| 07/29/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 12/23/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: PRIMARY CARE | ||||||
| 12/14/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: UROLOGY | ||||||
| 11/09/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: UROLOGY | ||||||
| 10/26/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: UROLOGY | ||||||
| 09/14/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: UROLOGY | ||||||
| 08/17/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: UROLOGY | ||||||
| 07/29/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Diabetes Care | ||||||
| 06/08/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: UROLOGY | ||||||
| 04/06/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $1.21 | General |
| Category: UROLOGY | ||||||
| 04/01/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.95 | General |
| 03/23/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: UROLOGY | ||||||
| 03/09/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: UROLOGY | ||||||
| 05/01/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 03/13/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 03/12/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.69 | General |
| 03/03/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 2,269 | 3,673 | $249,579 | $105,765 |
| 2022 | 33 | 2,132 | 2,947 | $227,598 | $99,446 |
| 2021 | 41 | 2,776 | 4,306 | $285,655 | $120,560 |
| 2020 | 42 | 2,919 | 4,187 | $270,758 | $105,752 |
Total Patients
10,096
Total Services
15,113
Medicare Billing
$431,523
Procedure Codes
154
All Medicare Procedures & Services
154 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 211 | 446 | $85,186 | $38,917 | 45.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 161 | 161 | $38,640 | $20,117 | 52.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 80 | 80 | $6,631 | $5,748 | 86.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 86 | $11,180 | $4,844 | 43.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 201 | 426 | $4,260 | $3,578 | 84.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 162 | 274 | $14,522 | $3,556 | 24.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 75 | 119 | $7,616 | $3,405 | 44.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 166 | 292 | $18,688 | $2,995 | 16.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 95 | 156 | $7,332 | $2,568 | 35.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 87 | 87 | $3,480 | $2,567 | 73.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 158 | 285 | $6,555 | $2,143 | 32.7% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2023 | 14 | 14 | $3,010 | $1,957 | 65.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 92 | 172 | $5,332 | $1,612 | 30.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 65 | 103 | $4,429 | $1,508 | 34.0% |
| 82746 | Folic acid level, serum | Office | 2023 | 46 | 66 | $2,838 | $936.65 | 33.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 23 | $1,610 | $925.26 | 57.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 51 | 51 | $2,040 | $918.51 | 45.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 39 | 56 | $2,408 | $748.16 | 31.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 19 | $1,824 | $733.86 | 40.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 51 | 81 | $3,807 | $716.04 | 18.8% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 35 | 51 | $1,428 | $637.50 | 44.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 47 | $2,444 | $452.23 | 18.5% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 28 | 57 | $1,710 | $444.46 | 26.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 43 | 77 | $1,232 | $435.82 | 35.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 21 | 21 | $1,113 | $397.32 | 35.7% |
About Dr. Paolo Pastore, MD
Dr. Paolo Pastore, MD is a Family Medicine healthcare provider based in Cicero, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174502850.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paolo Pastore, MD has received a total of $4,452 in payments from pharmaceutical and medical device companies, with $54.59 received in 2024. These payments were reported across 329 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,324).
As a Medicare-enrolled provider, Pastore has provided services to 10,096 Medicare beneficiaries, totaling 15,113 services with total Medicare billing of $431,523. Data is available for 4 years (2020–2023), covering 154 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cicero, NY
- Active Since 01/11/2006
- Last Updated 11/06/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174502850
Products in Payments
- Victoza (Drug) $225.17
- ANORO (Drug) $205.80
- Ozempic (Drug) $201.14
- FARXIGA (Drug) $196.11
- TRELEGY ELLIPTA (Drug) $192.61
- Saxenda (Drug) $188.65
- TRULICITY (Drug) $140.60
- MYRBETRIQ (Drug) $135.27
- JANUVIA (Drug) $118.35
- STIOLTO (Drug) $116.96
- Belviq (Drug) $114.83
- BREO (Drug) $109.19
- BEVESPI AEROSPHERE (Drug) $108.69
- SPIRIVA RESPIMAT (Drug) $105.04
- ASMANEX (Drug) $101.00
- SOLIQUA (Drug) $89.19
- SYMBICORT (Drug) $87.34
- TOUJEO (Drug) $83.16
- Vascepa (Drug) $79.65
- MYDAYIS (Drug) $78.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cicero
Daniel Rancier, Md, MD
Family Medicine — Payments: $12,897
Family Medicine $12,897
Amado Rueda, Md, MD
Family Medicine — Payments: $11,222
Family Medicine $11,222
Hernan Reyes, Md, MD
Family Medicine — Payments: $10,362
Family Medicine $10,362
Rosaura Licea, Md, MD
Family Medicine — Payments: $8,416
Family Medicine $8,416
Hemlata Meena, M.d, M.D
Family Medicine — Payments: $8,405
Family Medicine $8,405
Dennis Nave, Md, MD
Family Medicine — Payments: $6,961
Family Medicine $6,961